Anaplastic Large Cell Lymphoma Completed Phase 1 Trials for Imatinib (DB00619)

Also known as: Lymphomas, Anaplastic Large-Cell / Anaplastic large-cell lymphoma / Large cell (Ki-1+) lymphoma / Lymphoma, Large-Cell, Anaplastic / Anaplastic large cell lymphoma, CD30-positive

IndicationStatusPhase
DBCOND0028602 (Anaplastic Large Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00025415Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionTreatment